PSMA and Integrin αvβ3 Dual-Targeted Radioligands for Prostate Cancer Targeted Radionuclide Therapy.
- DOI
- 10.1021/acs.jmedchem.6c01818
- Published
- 2026 Aug 13
- Container
- Journal of medicinal chemistry
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1021/acs.jmedchem.6c01818,
title = {PSMA and Integrin αvβ3 Dual-Targeted Radioligands for Prostate Cancer Targeted Radionuclide Therapy.},
author = {Qi X and Li Z and Wang J and Chen Q and Qin Y and Zheng X and Wang D and Huang Q and Wang J and Zhang S and Qian W and Yang L and Zhu R and Zhou G and Wang G},
year = {2026},
journal = {Journal of medicinal chemistry},
doi = {10.1021/acs.jmedchem.6c01818},
url = {https://doi.org/10.1021/acs.jmedchem.6c01818}
}RIS
TY - JOUR TI - PSMA and Integrin αvβ3 Dual-Targeted Radioligands for Prostate Cancer Targeted Radionuclide Therapy. AU - Qi X AU - Li Z AU - Wang J AU - Chen Q AU - Qin Y AU - Zheng X AU - Wang D AU - Huang Q AU - Wang J AU - Zhang S AU - Qian W AU - Yang L AU - Zhu R AU - Zhou G AU - Wang G PY - 2026 JO - Journal of medicinal chemistry DO - 10.1021/acs.jmedchem.6c01818 UR - https://doi.org/10.1021/acs.jmedchem.6c01818 ER -
APA
X, Q., Z, L., J, W., Q, C., Y, Q., X, Z., D, W., Q, H., J, W., S, Z., W, Q., L, Y., R, Z., G, Z., & G, W. (2026). PSMA and Integrin αvβ3 Dual-Targeted Radioligands for Prostate Cancer Targeted Radionuclide Therapy.. Journal of medicinal chemistry. https://doi.org/10.1021/acs.jmedchem.6c01818
Source records
- pubmed · retrieved 2026-09-26T11:47:39.162Z